Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Spain's Esteve sells a plant then buys one as it refocuses on specialty drugs
Spain's Esteve sells a plant then buys one as it refocuses on specialty drugs
Spain's Esteve is picking up a German manufacturing site with a deal to buy Berlin-based Riemser from private equity firm Ardian.
Israeli researchers develop decoy molecule against deadly animal-to-human viruses
Israeli researchers develop decoy molecule against deadly animal-to-human viruses
JERUSALEM, Jan.
New anti-cancer treatment developed by Hong Kong researchers significantly reduces tumour size
New anti-cancer treatment developed by Hong Kong researchers significantly reduces tumour size
HONG KONG, Jan.
Mylan Initiates Voluntary Nationwide Recall of Three Lots of Nizatidine Capsules, USP, Due to the Detection of Trace Amounts of NDMA (N-Nitrosodimethylamine) Impurity Found in the Active Pharmaceutical Ingredient Manufactured by Solara Active Pharma Scien
Mylan Initiates Voluntary Nationwide Recall of Three Lots of Nizatidine Capsules, USP, Due to the Detection of Trace Amounts of NDMA (N-Nitrosodimethylamine) Impurity Found in the Active Pharmaceutical Ingredient Manufactured by Solara Active Pharma Scien
Mylan N.
Merck's Keytruda wins U.S. FDA approval for bladder cancer
Merck's Keytruda wins U.S. FDA approval for bladder cancer
(Reuters) - The U.
Boehringer Ingelheim's bet on Chinese CDMO market pays off with BeiGene's mAb approval
Boehringer Ingelheim's bet on Chinese CDMO market pays off with BeiGene's mAb approval
Germany-based Boehringer Ingelheim opened this €70 million biologics manufacturing facility in Shanghai to produce cell-based drugs targeted primarily at China.
Avacta and Daewoong Pharmaceutical Form Immunotherapy Focused Joint Venture
Avacta and Daewoong Pharmaceutical Form Immunotherapy Focused Joint Venture
Avacta Group plc (AIM.
Bristol-Myers Squibb Completes Divestment of Manufacturing Facility in Anagni, Italy
Bristol-Myers Squibb Completes Divestment of Manufacturing Facility in Anagni, Italy
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE.
Towa adds EU production in deal for Spanish generics maker
Towa adds EU production in deal for Spanish generics maker
Japanese generics maker Towa Pharmaceutical has scored its first European manufacturing site with the purchase of the generics unit of Spain’s Esteve.
CDMO WuXi STA opens manufacturing facility to produce oligonucleotides
CDMO WuXi STA opens manufacturing facility to produce oligonucleotides
CDMO WuXi STA is building out its manufacturing site in Changzhou, China in stages.
With cancer kickoff, Amgen bets on BeiGene's fast-growing Chinese sales force
With cancer kickoff, Amgen bets on BeiGene's fast-growing Chinese sales force
Compared with multinational rivals such as Novartis, Roche and AstraZeneca, Amgen didn’t have a strong oncology presence in China.
'Totally bummed' Nobel Prize winner admits a 'painful' mistake
'Totally bummed' Nobel Prize winner admits a 'painful' mistake
TORONTO -- A Nobel Prize winner has admitted she “did not do her job well” after a scientific paper published last year was retracted.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand